PharmaCielo has achieved Colombian GMP Certification for Phytotherapeutics manufactured with its extracts and proprietary cultivars from the Colombian National Food and Drug Surveillance Institute (“INVIMA”). The Company's Rionegro facility is one of Colombia's largest cannabis processing centres, and one of the largest in the world today, capable of processing 360 tonnes of biomass annually.
Bill Petron, CEO of PharmaCielo, commented, “GMP certification is the gold standard for the quality assurance of extract production globally, and PharmaCielo’s achievement of this milestone confirms that the Company’s processes and products are world class. The next step for PharmaCielo is the achievement of EU-GMP certification. We have already been producing to EU-GMP standards since early 2021, are launching an independent audit with a potential customer in the coming weeks and are on track to receive formal certification six months thereafter. PharmaCielo has a portfolio of high-quality, GMP certified Phytotherapeutics, Colombia’s largest cultivation, processing, and extraction footprint, a global low-cost advantage, and a robust sales pipeline. We are positioned to scale and generate value for shareholders.”